Earnings Call Summary | Cutera(CUTR.US) Q2 2024 Earnings Conference
Earnings Call Summary | Cutera(CUTR.US) Q2 2024 Earnings Conference
Non-GAAP loss from operations for Q2 2024 was $21.3 million.The following is a summary of the Cutera, Inc (CUTR) Q2 2024 Earnings Call Transcript:
以下是古特拉公司（Cutera, Inc）2024年第二季度業績會議呼叫記錄摘要：
Financial Performance:
金融業績：
Q2 2024 revenue was $34.4 million, down from $61.8 million in Q2 2023, a 44% decrease year-over-year.
Non-GAAP gross profit for Q2 2024 was $9.6 million, with a gross margin rate of 28.8%.
Non-GAAP loss from operations for Q2 2024 was $21.3 million.
Cutera provided revised full-year revenue guidance to $140 million to $145 million from a prior range of $160 million to $170 million.
2024年第二季度營業收入爲3440萬美元，較2023年第二季度的6180萬美元下降44%。
2024年第二季度非通用會計原則毛利潤爲960萬美元，毛利率爲28.8%。
2024年第二季度非通用會計原則運營虧損2130萬美元。
古特拉公司修訂全年營業收入指引至1.4億至1.45億美元，之前爲1.6億至1.7億美元的區間。
Business Progress:
業務進展：
International launch of AviClear was successful, with over 70 systems sold outside of North America.
New capital sales organization structure implemented in North America.
Partnership established with L'Oreal's SkinCeuticals business in Japan, expected to launch in Q4 2024.
AviClear國際推出非常成功，在北美以外銷售了超過70套系統。
在北美實施了新的資本銷售組織結構。
與L'Oreal的SkinCeuticals業務在日本建立合作關係，預計於2024年第四季度推出。
Opportunities:
機會：
The international success of AviClear and restructuring in North America present opportunities for growth and improved sales productivity.
The new partnership with L'Oreal's SkinCeuticals in Japan represents potential growth in skincare.
AviClear在國際上的成功和北美的重組爲公司的增長和銷售生產率的提高帶來了機會。
與L'Oreal公司的SkinCeuticals在日本建立的新合作關係代表着皮膚護理業務的潛在增長。
Risks:
風險：
Continued macroeconomic pressures affecting capital equipment revenue, particularly in North America.
High sales force turnover in North America impacting short-term revenue.
持續存在的宏觀經濟壓力對資本設備營收產生影響，尤其是在北美。
北美銷售團隊的高流失率對短期營收產生影響。
More details: Cutera IR
更多詳情請參見古特拉公司（Cutera）投資者關係頁面。
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：如需更全面的詳情，請參閱投資人關係網站。本文僅供投資者參考，不作任何指引或建議。
譯文內容由第三人軟體翻譯。